Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
This study is ongoing, but not recruiting participants.
Study NCT00140257 Information provided by Bispebjerg Hospital
First Received: August 30, 2005 Last Updated: December 30, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Additional conditions recognized in this trial
Acute Coronary Syndrome
Depressive Disorder
Syndrome
More general conditions related to this trial
Behavioral Symptoms
Cardiovascular Diseases
Disease
Heart Diseases
Mental Disorders
Mood Disorders
Myocardial Ischemia
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Escitalopram
Additional drug interventions recognized in this trial
Citalopram
Dexetimide
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Bispebjerg Hospital
H. Lundbeck A/S
The Danish Heart Association
The Danish Medical Research Council
Back to top of Main Content